Higher compliance and retention rates are translating to better data for our clients.
As a founding member of DTRA, ObvioHealth is committed to driving the future of decentralized clinical trials in the industry.
Taking COVID Research Out of the Clinic and into the Home:
Early Insights on a Virtual Interventional Trial
This presentation examines the virtual trial design through the lens of our past experiences: 40+ fully virtually or hybrid studies conducted over 4+ years. We use real-world case studies to give you a clearer understanding of the various virtual components that increase compliance, engagement, and retention.
Fill out the form below for access to the webinar:
As a founding member of DTRA, ObvioHealth is committed to driving the future of decentralized clinical trials in the industry.
The presentation includes insights and anecdotes from real case studies:
ObvioHealth has conducted 42 studies in 28 countries with more than 25,000 participants. Click through the therapeutic areas below to see some of our case studies.
ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.
ObvioHealth's Numbers
Up to 4x
Faster Recruitment
3 mo ObvioHealth average vs 12 mo benchmark for site-based trials
89%
Retention
average retention vs. 70% benchmark for traditional trials
90%
ePro Compliance
average per study (digital questionnaires, daily ediary, etc.).
